Unibest
← Back to patent-cliff list

CAS 1032815-08-9

4-chloro-5-(1,3-dioxolan-2-yl)-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine

Codes: PEMIGA-007

Application context (from source-drug indications)

MyelomaPemigatinibLymphomaPemigatinibBile duct cancerPemigatinibCholangiocarcinomaPemigatinibBiliary tract cancerPemigatinib

Source drugs (routes using this intermediate)

DrugTierExpiry
PemigatinibTier C — Watch / trade2032

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.